中文 | ENG

第58卷 第1期 2025-1
Ensuring authorship qualification in clinical research articles: A focus on surgical therapy studies

.........................

第58卷 第1期 2025-1
Estimated risk for transfusion of monkeypox contaminated perioperative blood transfusion: A call to action for stronger regulations and testing protocols

.........................

第58卷 第1期 2025-1
Insights into traumatic and crisis surgery: Implications of data analysis in conflict zones

.........................

第58卷 第1期 2025-1
Tongue peeling as an adverse reaction with use of micronized purified flavonoid: A case report

.........................

第58卷 第1期 2025-1
Pilonidal sinus of scrotum: A rare clinical entity

.........................

第58卷 第1期 2025-1
Incidental autopsy finding of retiform hemangioendothelioma of the spleen

.........................

第58卷 第1期 2025-1
Retroperitoneal laparoscopy for hydronephrosis due to multiple fibroepithelial polyps: A case series

.........................

第58卷 第1期 2025-1
Case reports of type 1 cystic biliary atresia—A rare variant of biliary atresia alongwith reviewof literature

.........................

第58卷 第1期 2025-1
The predictors of intraoperative surgical expenses in liver resection for hepatocellular carcinoma

.........................

第58卷 第1期 2025-1
Intracorporeal anastomosis versus extracorporeal anastomosis following laparoscopic right hemicolectomy: Surgical outcomes of a single-center observational study

.........................

第58卷 第1期 2025-1
Quality of life and spiritual health in motorcycle accident survivors: An analysis using the SF-36 Questionnaire and Spiritual Scale

.........................

第58卷 第1期 2025-1
Plastin 3 expression in circulating tumor cells as a predictor of cancer status in patients with prostate cancer

.........................

第57卷 第6期 2024-11
Emerging robot-guided techniques in endodontic microsurgery

.........................

第57卷 第6期 2024-11
Management of subcapsular hematoma after living donor liver transplant

.........................

第57卷 第6期 2024-11
Urethral pseudodiverticulum with left-sided nonfunctioning kidney: Case report

.........................

第57卷 第6期 2024-11
Strategy to minimize surgical defect of dermatofi brosarcoma protuberans

.........................

第57卷 第6期 2024-11
Rapunzel syndrome—An uncommon disease with varied common presentations

.........................

第57卷 第6期 2024-11
Minimally invasive approaches to management of acute necrotizing pancreatitis

.........................

第57卷 第6期 2024-11
Innovative surgical technique: Addressing ethical concerns

.........................

第57卷 第6期 2024-11
Emergency surgery and HIV screening, clinical or universal scenarios?

.........................
登入帳號才能閱讀全文
 
篇名 The amputation and mortality rates of diabetic patients with critical limb ischemia: A nationwide population-based follow-up study in Taiwan*
作者 Kuo-Chun Liao, Shih-Feng Weng, Chung-Hsi Hsing, Cheng Liu,Jhi-Joung Wang, Kuo-Feng Huang, Chin-Chen Chu
卷期/出版年月 46卷3期 (2013/6)
頁次 79-86
摘要 Purpose: To describe the epidemiological profiles and the amputation and mortality rates of diabetic patients in Taiwan with critical limb ischemia. Materials and methods: Data were collected from the Longitudinal Health Insurance Database 2000 (LHID2000), a database composed of one million randomly selected beneficiaries in Taiwan. To measure major amputation and mortality, diabetic patients with critical limb ischemia (CLI) were identified by specific ICD-9-CM diagnostic, procedure, and order codes. The patients were traced until the end of 2009. Cox proportional hazard regressions were used to determine the crude and adjusted hazard ratios for the risk factors for amputation and mortality during the follow-up period. Results: We identified 6418 diabetic patients with CLI from the LHID database during 1997e2006. Of these patients, 256 (3.99%) patients underwent surgical revascularization and 6418 (96.01%) patients received conservative treatment only. The revascularization cohort had more comorbidities than the surgical group (e.g., cardiovascular, 13.28% vs. 8.62%, respectively, p=0.0099; renal, 23.05% vs. 5.34%, respectively, p < 0.0001). The amputation and mortality rates for diabetic CLI patients in Taiwan were 5.75% and 18.62%, respectively. Male gender, an age of greater than 50 years old, and cardiovascular and renal comorbidities were identified as risk factors for amputation. The risk factors for mortality also included old age (i.e.,>50 years), male gender, and comorbid cardiovascular, renal, neurological, and pulmonary diseases. Conclusion: Diabetic patients who needed surgical revascularization or who needed conservative treatment for CLI had different comorbid profiles. The common risk factors for amputation and mortality in diabetic CLI patients include male gender, age of>50 years, and concurrent cardiovascular and renal diseases.
關鍵詞 amputation;critical limb ischemia;diabetes;revascularization
分類 Original Article

台灣外科醫學會雜誌 © 2006 Taiwan Surgical Association All Rights Reserved
會 址:台北市南京東路五段 31 號 3 樓
電 話:(02) 2769-7845 傳 真:(02) 2746-7149 Email: journal@surgery.org.tw